"Leukemic cells hijack stromal bioelectricity to reprogram…
0 reactions
"Leukemic cells hijack stromal bioelectricity to reprogram the bone marrow niche" by Martina Pigazzi
This video features a presentation by Martina Pigazzi regarding the role of stromal bioelectricity in reprogramming the bone marrow niche in cases of pediatric Acute Myeloid Leukemia (AML).
\### Key Takeaways & Findings
•Modeling the Niche: Pigazzi discusses the development of a 3D scaffold model (hydroxyapatite and collagen) to mimic the bone marrow microenvironment and study how leukemia interacts with surrounding cells (0:05:31-0:06:40).
•Leukemic Reprogramming: AML blasts reprogram mesenchymal stromal cells (MSCs) to support tumor survival, creating a permissive niche for leukemia progression (0:09:02-0:10:33).
•Bioelectric Mechanisms: The study identified that leukemic MSCs have lower expression of the CaV1.2 calcium channel, leading to altered calcium dynamics and membrane depolarization (0:13:51-0:15:35).
•Potential Treatments: The research suggests that targeting this pathway, either by using Lercanidipine to trigger leukemic MSC death or through gene therapy to restore CaV1.2 expression, can help revert the leukemic niche back to a healthy state (0:10:47-0:12:47, 0:25:35-0:28:59).
\### Conclusion
Depolarization of stromal cells due to CaV1.2 down-regulation supports leukemia. Re-establishing healthy bioelectric signaling in the bone marrow represents a potential strategy for improving AML treatments (0:30:17-0:31:13).
#animals
This video features a presentation by Martina Pigazzi regarding the role of stromal bioelectricity in reprogramming the bone marrow niche in cases of pediatric Acute Myeloid Leukemia (AML).
\### Key Takeaways & Findings
•Modeling the Niche: Pigazzi discusses the development of a 3D scaffold model (hydroxyapatite and collagen) to mimic the bone marrow microenvironment and study how leukemia interacts with surrounding cells (0:05:31-0:06:40).
•Leukemic Reprogramming: AML blasts reprogram mesenchymal stromal cells (MSCs) to support tumor survival, creating a permissive niche for leukemia progression (0:09:02-0:10:33).
•Bioelectric Mechanisms: The study identified that leukemic MSCs have lower expression of the CaV1.2 calcium channel, leading to altered calcium dynamics and membrane depolarization (0:13:51-0:15:35).
•Potential Treatments: The research suggests that targeting this pathway, either by using Lercanidipine to trigger leukemic MSC death or through gene therapy to restore CaV1.2 expression, can help revert the leukemic niche back to a healthy state (0:10:47-0:12:47, 0:25:35-0:28:59).
\### Conclusion
Depolarization of stromal cells due to CaV1.2 down-regulation supports leukemia. Re-establishing healthy bioelectric signaling in the bone marrow represents a potential strategy for improving AML treatments (0:30:17-0:31:13).
#animals
| 3,000 mlx | |
| 4 | |
| 0 |